Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kecheng Xu

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Oncotargets and Therapy|September 13, 2017
Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancerShuzhen Liang, Kecheng Xu, Lizhi Niu, et al.
Immunology Letters|March 10, 2017
Prospective study of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced renal cell cancerMao Lin, Kecheng Xu, Shuzhen Liang, et al.
Molecular Immunology|October 18, 2017
Tumor cryoablation in combination with natural killer cells therapy and Herceptin in patients with HER2-overexpressing recurrent breast cancerShuzhen Liang, Lizhi Niu, Kecheng Xu, et al.
Biotechnology and Applied Biochemistry|February 16, 2012
The establishment of the duplex real-time RT-PCR assay for the detection of CD44v6 in pancreatic cancer patients and clinical applicationGang Zhou, David Chiu, Dajiang Qin, et al.
Molecular Biotechnology|March 3, 2012
The efficacy evaluation of cryosurgery in pancreatic cancer patients with the expression of CD44v6, integrin-β1, CA199, and CEAGang Zhou, David Chiu, Dajiang Qin, et al.
Oncotarget|November 16, 2017
Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancerMao Lin, Shuzhen Liang, Xiaohua Wang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 26, 2018
Circulating Tumor DNA as a Sensitive Marker in Patients Undergoing Irreversible Electroporation for Pancreatic CancerMao Lin, Mohammed Alnaggar, Shuzhen Liang, et al.
Immunology Letters|April 11, 2017
Short-term clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell for treating metastatic pancreatic cancerMao Lin, Shuzhen Liang, Xiaohua Wang, et al.
Cryobiology|July 13, 2013
Combination percutaneous cryotherapy and iodine-125 seed implantation for unresectable malignant thymoma: experience in 19 patientsZhikai Zhang, Binghui Wu, Lizhi Niu, et al.
Technology in Cancer Research & Treatment|June 1, 2017
Irreversible Electroporation Ablation of an Unresectable Fibrous Sarcoma With 2 Electrodes: A Case ReportZilin Qin, Jianying Zeng, Guifeng Liu, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Oncotargets and Therapy|September 13, 2017
Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancerShuzhen Liang, Kecheng Xu, Lizhi Niu, et al.
Immunology Letters|March 10, 2017
Prospective study of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced renal cell cancerMao Lin, Kecheng Xu, Shuzhen Liang, et al.
Molecular Immunology|October 18, 2017
Tumor cryoablation in combination with natural killer cells therapy and Herceptin in patients with HER2-overexpressing recurrent breast cancerShuzhen Liang, Lizhi Niu, Kecheng Xu, et al.
Biotechnology and Applied Biochemistry|February 16, 2012
The establishment of the duplex real-time RT-PCR assay for the detection of CD44v6 in pancreatic cancer patients and clinical applicationGang Zhou, David Chiu, Dajiang Qin, et al.
Molecular Biotechnology|March 3, 2012
The efficacy evaluation of cryosurgery in pancreatic cancer patients with the expression of CD44v6, integrin-β1, CA199, and CEAGang Zhou, David Chiu, Dajiang Qin, et al.
Oncotarget|November 16, 2017
Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancerMao Lin, Shuzhen Liang, Xiaohua Wang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 26, 2018
Circulating Tumor DNA as a Sensitive Marker in Patients Undergoing Irreversible Electroporation for Pancreatic CancerMao Lin, Mohammed Alnaggar, Shuzhen Liang, et al.
Immunology Letters|April 11, 2017
Short-term clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell for treating metastatic pancreatic cancerMao Lin, Shuzhen Liang, Xiaohua Wang, et al.
Cryobiology|July 13, 2013
Combination percutaneous cryotherapy and iodine-125 seed implantation for unresectable malignant thymoma: experience in 19 patientsZhikai Zhang, Binghui Wu, Lizhi Niu, et al.
Technology in Cancer Research & Treatment|June 1, 2017
Irreversible Electroporation Ablation of an Unresectable Fibrous Sarcoma With 2 Electrodes: A Case ReportZilin Qin, Jianying Zeng, Guifeng Liu, et al.
Pageof 8